Mechanisms and consequences of sickle cell disease-induced cycling in hematopoietic stem cells
镰状细胞病诱导造血干细胞循环的机制和后果
基本信息
- 批准号:10464657
- 负责人:
- 金额:$ 6.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAbnormal HemoglobinsAgeAge-MonthsAgingAnimal DiseasesAnimalsAspirate substanceAutologousAutologous TransplantationBiochemicalBiological AssayBone MarrowCancer BiologyCarrying CapacitiesCell CompartmentationCell CycleCell ProliferationCellsChronicClinicalClinical TrialsDNA DamageData AnalysesData SetEnvironmentEpigenetic ProcessErythrocytesErythropoiesisExposure toFlow CytometryFrequenciesFunctional disorderGenesGenetic TranscriptionGleanGoalsHealthHematologic NeoplasmsHematological DiseaseHematologyHematopoieticHematopoietic NeoplasmsHematopoietic Stem Cell MobilizationHematopoietic Stem Cell TransplantationHematopoietic Stem Cell subsetsHematopoietic stem cellsHemolysisHumanImmuneImpairmentIn VitroInflammationInheritedInvestigationKnowledgeLaboratoriesLeadLearningLifeMediatingMentorshipMolecularMolecular ProbesMolecular ProfilingMorbidity - disease rateMorphologyMusMutationMyelogenousOrganOutputOxygenPainPathway interactionsPatientsPhenotypePilot ProjectsPloidiesPositioning AttributePostdoctoral FellowRegimenResearch PersonnelResource DevelopmentResourcesRiskSafetySaint Jude Children&aposs Research HospitalSickle CellSickle Cell AnemiaSourceStressTestingTimeTrainingTransgenic OrganismsTranslatingTransplantationWorkXenograft procedureagedcareer developmentcell agecell injurychemotherapycurative treatmentscytokinedisorder controlexhaustionfitnessgene therapyhematopoietic stem cell differentiationhemoglobin Bhemoglobin polymerimmune activationimprovedin vivoinsightmortalitymouse modelnovelpolymerizationpost-transplantprematurepromoterself-renewalsicklingstem cell biologystem cell functionsystemic inflammatory responsetraining opportunitytranscriptome sequencing
项目摘要
Project Summary
Sickle cell disease (SCD) is a painful debilitating life-long condition resulting from mutations in the gene encoding
hemoglobin β subunit, causing abnormal hemoglobin polymerization leading to hemolysis, repeated
vasooclusion, and chronic systemic inflammation resulting in substantial global morbidity and early mortality.
Curative therapy for SCD relies on hematopoietic stem cell (HSC) transplantation, however the damaging effects
of SCD pathophysiology on HSCs remain uncharacterized and we seek to fill this gap in current knowledge. Our
preliminary studies show that HSCs display increased cycling in a transgenic SCD mouse model upon aging,
and myeloid lineage biased in vitro differentiation of SCD patient derived HSCs. As a postdoctoral fellow in the
McKinney-Freeman laboratory, I will investigate the functional consequences and molecular mechanisms
underlying SCD mediated HSC cycling in a murine model and translate these findings to human HSC during
SCD. In Aim 1, I will use colony formation assays, limiting dilution primary and secondary HSC transplantation,
and serial exposure to chemotherapy to assess the detrimental impact of SCD-induced cycling on HSC
frequency and function. In Aim 2, I will probe the molecular and epigenetic dysregulation underlying increased
HSC cycling during SCD. HSCs isolated from SCD and control mice will be subjected to bulk RNA-seq and
ATAC-seq to define transcriptional dysregulation correlated with changes in gene promoter accessibility
meditating increased cycling. Finally, I will translate our findings to humans by interrogating cell cycle
dysregulation in HSCs isolated from SCD patients (Aim 3). SCD patient-derived bone marrow aspirates will be
profiled for frequency of phenotypic HSCs and alterations in cell cycle status by flow cytometry and ex vivo EdU
incorporation. Lineage potential and hematopoietic output of SCD HSCs will be analyzed by colony formation
and in vitro single HSC differentiation assays. Lastly, SCD HSC repopulating potential and self-renewal will be
examined by limiting dilution primary and secondary transplantation into human cytokine expressing immune
deficient mice. Together the proposed studies serve to deepen our understanding of a previously unexplored
aspect of HSC biology by examining the impact of SCD. Greater understanding of SCD mediated mechanisms
of HSC impairment become exceptionally important as autologous HSC transplantation following gene editing
or gene therapy for SCD improve and increase in frequency. These aims draw on my prior training in cancer
biology of hematologic malignancies but also provide abundant novel training opportunities in the field of HSC
biology and for professional career development. The McKinney-Freeman lab and St. Jude Children’s Research
Hospital are ideal environments in which to receive training in the study HSC biology, combining state-of-the-art
institutional resources, career development resources, and excellent mentorship with the singular goal of
advancing to an independent academic primary investigator position.
项目摘要
镰状细胞病(SCD)是一种痛苦的衰弱的终身条件所造成的基因编码突变,
血红蛋白β亚基,引起异常血红蛋白聚合,导致溶血,反复
血管闭塞和慢性全身性炎症,导致大量的全球发病率和早期死亡率。
SCD的治愈性治疗依赖于造血干细胞(HSC)移植,然而,
SCD病理生理学在HSC上的作用仍然没有特征化,我们试图填补现有知识中的这一空白。我们
初步研究显示在转基因SCD小鼠模型中HSC在老化时表现出增加的循环,
和髓系偏向的SCD患者来源的HSC的体外分化。作为一名博士后研究员,
麦金尼-弗里曼实验室,我将研究功能后果和分子机制
在小鼠模型中,基础SCD介导的HSC循环,并将这些发现转化为人类HSC,
SCD。在目标1中,我将使用集落形成试验,有限稀释的初级和次级HSC移植,
和连续暴露于化疗以评估SCD诱导的循环对HSC的有害影响
频率和功能。在目标2中,我将探讨增加的基因表达的分子和表观遗传失调。
SCD期间的HSC循环。将从SCD和对照小鼠分离的HSC进行批量RNA-seq和测序。
ATAC-seq定义与基因启动子可及性变化相关的转录失调
冥想增加了循环。最后,我将通过询问细胞周期,
在从SCD患者分离的HSC中的异常调节(目的3)。SCD患者来源的骨髓穿刺液将
通过流式细胞术和离体EdU分析表型HSC的频率和细胞周期状态的改变
合并。将通过集落形成分析SCD HSC的谱系潜力和造血输出
和体外单一HSC分化测定。最后,SCD HSC的再生潜力和自我更新将是
通过有限稀释初次和二次移植到表达免疫的人细胞因子中进行检查
缺陷小鼠这些拟议的研究有助于加深我们对以前未探索的
HSC生物学方面通过检查SCD的影响。更好地理解SCD介导的机制
在基因编辑后自体HSC移植时,HSC损伤变得异常重要
或基因治疗对SCD的改善和频率增加。这些目标都是基于我之前在癌症方面所接受的培训
血液恶性肿瘤的生物学,但也提供了丰富的新的培训机会,在HSC领域
生物学和专业职业发展。麦金尼-弗里曼实验室和圣裘德儿童研究
医院是理想的环境中接受培训的研究HSC生物学,结合国家的最先进的
机构资源、职业发展资源和优秀的导师,其唯一目标是
晋升为独立学术主要研究员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Aditya Shirish Barve其他文献
Aditya Shirish Barve的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Aditya Shirish Barve', 18)}}的其他基金
Mechanisms and consequences of sickle cell disease-induced cycling in hematopoietic stem cells
镰状细胞病诱导造血干细胞循环的机制和后果
- 批准号:
10676740 - 财政年份:2022
- 资助金额:
$ 6.76万 - 项目类别:
相似海外基金
Development of the simple-rapid diagnosis method of hemoglobinopathies, thalassemias and abnormal hemoglobins
血红蛋白病、地中海贫血和血红蛋白异常的简单快速诊断方法的开发
- 批准号:
14572193 - 财政年份:2002
- 资助金额:
$ 6.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of the rapid diagnosis method of hemoglobinopathies, thalssemias and abnormal hemoglobins.
开发血红蛋白病、地中海贫血和血红蛋白异常的快速诊断方法。
- 批准号:
12672259 - 财政年份:2000
- 资助金额:
$ 6.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ABNORMAL HEMOGLOBINS, CATIONS, AND VOLUME IN RED CELLS
红细胞中的血红蛋白、阳离子和体积异常
- 批准号:
3350686 - 财政年份:1986
- 资助金额:
$ 6.76万 - 项目类别:
ABNORMAL HEMOGLOBINS, CATIONS, AND VOLUME IN RED CELLS
红细胞中的血红蛋白、阳离子和体积异常
- 批准号:
3350687 - 财政年份:1986
- 资助金额:
$ 6.76万 - 项目类别:
A Study of Abnormal Hemoglobins and Varieties of Plasma Proteins
异常血红蛋白和血浆蛋白种类的研究
- 批准号:
6320879 - 财政年份:1963
- 资助金额:
$ 6.76万 - 项目类别:














{{item.name}}会员




